Literature DB >> 21401312

Timing of operative vaginal delivery and associated perinatal outcomes in nulliparous women.

Yvonne W Cheng1, Brian L Shaffer, Katherine Bianco, Aaron B Caughey.   

Abstract

OBJECTIVE: To compare perinatal outcomes in nulliparous women who had operative vaginal delivery early during second stage (1-3 h) to those who delivered vaginally with a prolonged second stage (>3 h).
METHODS: This is a retrospective cohort study of nulliparas with term, singleton, vaginal deliveries beyond the first hour of second stage. Women who underwent operative vaginal deliveries (OVD) during 1-3 h of the second stage were compared to women who delivered vaginally but with a second stage duration of >3 h. Perinatal outcomes were examined using chi-square test, and potential confounders were controlled for using multivariable logistic regression analysis.
RESULTS: Nulliparas delivered vaginally beyond 3 h of second stage had lower odds of third or fourth degree perineal lacerations (aOR = 0.63, 95% CI 0.51-0.77), neonatal cephalohematoma (aOR = 0.48, 95% CI 0.28-0.83) and admissions to intensive care nursery (aOR = 0.70, 95% CI 0.49-0.99) compared to operative vaginal deliveries during 1-3 h of second stage.
CONCLUSION: Compared to nulliparas who had operative vaginal deliveries performed early (1-3 h) in the second stage, women who delivered later (>3 h duration of second stage), either by spontaneous or operative vaginal delivery, had lower risk of third or fourth degree perineal lacerations without incurring risk of increased adverse neonatal outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21401312     DOI: 10.3109/14767058.2010.521872

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Duration of second stage of labor and instrumental delivery as risk factors for severe perineal lacerations: population-based study.

Authors:  Marija Simic; Sven Cnattingius; Gunnar Petersson; Anna Sandström; Olof Stephansson
Journal:  BMC Pregnancy Childbirth       Date:  2017-02-21       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.